<doc>
  <docmeta id="113hr4437ih">
    <bill congress="113" type="hr" number="4437" version="ih"/>
    <revision size="5671" annotations="0" status="complete" id="4" commit-time="2014-05-02T16:38:37Z" committer="mbohmer" doc="113hr4437ih/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H0FB46F8E214D457FBC4A4D8DC8E670DF" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4437 IH: Generic Drug Pricing Fairness Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-04-09</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4437</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140409">April 9, 2014</action-date>
			<action-desc>
        <sponsor name-id="C001093">Mr. Collins of Georgia</sponsor> (for himself and <cosponsor name-id="L000565">Mr. Loebsack</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards
			 under the Medicare prescription drug program to further transparency of
			 payment methodologies to pharmacies, and for other purposes.</official-title>
	</form>
	<legis-body id="H6C3782ED58F54A16A3ECDBAFF56DA36C" style="OLC">
		<section id="HE51DE2164E1F4BF1B28C21FEACC4D063" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Generic Drug Pricing Fairness Act" proposed="true">Generic Drug Pricing Fairness Act</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="H1A4CB6263E9C4F8CB57AA3ED4660E11D">
      <enum>2.</enum>
      <header>Pharmacy benefits manager standards under the Medicare program</header>
			<subsection id="H140C1305F8034979906E3A3E7D5F7277">
        <enum>(a)</enum>
        <header>In general</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–12/ss:b">Section 1860D–12(b) of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-112">
            <cato:entity-ref entity-type="uscode" value="usc/42/1395w–112/b">42 U.S.C. 1395w–112(b)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the
			 end the following new paragraphs:</text>
				<quoted-block display-inline="no-display-inline" id="HEBAF1660059843458CF51F9727523212" style="OLC">
					<paragraph id="HCE393CB1912E466490181D13556F881F">
            <enum>(7)</enum>
            <header>Pharmacy benefits manager transparency requirements</header>
            <text>Each contract entered into with a PDP sponsor under this part with respect to a prescription drug
			 plan offered by such sponsor shall provide that the PDP may not enter into
			 a contract with any pharmacy benefits manager (referred to in this
			 paragraph as a <quote>PBM</quote>) to manage the prescription drug coverage provided under such plan, or to control the costs of the
			 prescription drug coverage under such plan, unless the PBM adheres to the
			 following criteria when handling personally identifiable utilization and
			 claims data or other sensitive patient data:</text>
						<subparagraph id="H96183BFC32B1464EB1133BE2CD74978D">
              <enum>(A)</enum>
              <text>The PBM may not transmit any personally identifiable utilization or claims data, with respect to a
			 plan enrollee, to a pharmacy owned by a PBM if the plan enrollee has not
			 voluntarily elected in writing or via secure electronic means to fill that
			 particular prescription at the PBM-owned pharmacy.</text>
						</subparagraph>
            <subparagraph id="H1CDD299FA3524186B3ED07806F08FFDB">
              <enum>(B)</enum>
              <text>The PBM may not require that a plan enrollee use a retail pharmacy, mail order pharmacy, specialty
			 pharmacy, or other pharmacy entity providing pharmacy services in which
			 the PBM has an ownership interest or that has an ownership interest in the
			 PBM or provide an incentive to a plan enrollee to encourage the enrollee
			 to use a retail pharmacy, mail order pharmacy, specialty pharmacy, or
			 other pharmacy entity providing pharmacy services in which the PBM has an
			 ownership interest or that has an ownership interest in the PBM, if the
			 incentive is applicable only to such pharmacies.</text>
            </subparagraph>
          </paragraph>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="HE009F4CA97E44C07905FF604F39633A4">
        <enum>(b)</enum>
        <header>Regular update of prescription drug pricing standard</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–12/ss:b/p:6">Paragraph (6) of section 1860D–12(b) of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-112">
            <cato:entity-ref entity-type="uscode" value="usc/42/1395w–112/b">42 U.S.C. 1395w–112(b)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended
			 to read as follows:</text>
				<quoted-block display-inline="no-display-inline" id="H804874E7358C4C38958F2FCE1C0E4560" style="OLC">
					<paragraph id="HCF9A5B755CF840DFBA39B9EF666CB279">
            <enum>(6)</enum>
            <header>Regular update of prescription drug pricing standard</header>
						<subparagraph id="H06BABFD807FD4EFA97D589A978D68ECF">
              <enum>(A)</enum>
              <header>In general</header>
              <text display-inline="yes-display-inline">If the PDP sponsor of a prescription drug plan uses a standard for reimbursement (as described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–12/ss:b/p:6/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>) of pharmacies based on the cost of a drug, each contract
			 entered into with such sponsor under this part with respect to the plan
			 shall provide that the sponsor shall—</text>
							<clause id="HE6811E4025984344B0FB20BB2A017C1A">
                <enum>(i)</enum>
                <text>update such standard not less frequently than once every 7 days, beginning with an initial update
			 on January 1 of each year, to accurately reflect the market price of
			 acquiring the drug;</text>
							</clause>
              <clause id="H06A0D9BEC2CA4A1596AC5C620391B42D">
                <enum>(ii)</enum>
                <text>disclose to applicable pharmacies the sources used for making any such update;</text>
							</clause>
              <clause id="H683B972815AE4009B17755F032DD70A5">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">if the source for such a standard for reimbursement is not publicly available, disclose to the
			 applicable pharmacies all individual drug prices to be so updated in
			 advance of the use of such prices for the reimbursement of claims; and</text>
							</clause>
              <clause id="H5BA4BEF5705B415DA456D94413B43C88">
                <enum>(iv)</enum>
                <text display-inline="yes-display-inline">establish a process to appeal, investigate, and resolve disputes regarding individual drug prices
			 that are less than the pharmacy acquisition price for such drug.</text>
							</clause>
            </subparagraph>
            <subparagraph id="H458BDE175ADB44DBB12EE44492F7C92E">
              <enum>(B)</enum>
              <header>Prescription drug pricing standard defined</header>
              <text display-inline="yes-display-inline">For purposes of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–12/ss:b/p:6/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, a standard for reimbursement of a pharmacy is any methodology or
			 formula for varying the pricing of a drug or drugs during the term of the
			 pharmacy reimbursement contract that is based on the cost of the drug
			 involved, including drug pricing references and amounts that are based
			 upon average wholesale price, wholesale average cost, average manufacturer
			 price, average sales price, maximum allowable cost (MAC), or other costs,
			 whether publicly available or not.</text>
            </subparagraph>
          </paragraph>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="HA80E5BD8E6EF4F1B8D326A66B53742A5">
        <enum>(c)</enum>
        <header>Effective date</header>
        <text>The amendments made by this section shall apply to plan years beginning on or after January 1,
			 2015.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>